AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


15 January 2020

Inhibiting bacterial cooperation is an evolutionarily robust anti-biofilm strategy

15 January 2020

New strategy in the fight against antibiotic resistance

15 January 2020

Effect of tolerance on the evolution of antibiotic resistance under drug combinations

14 January 2020

VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning

14 January 2020

CARB-X funds Trellis Bioscience to support the development of a monoclonal antibody designed to disrupt superbugs’ protective coating so that antibiotics can kill them

11 January 2020

2020 Antimicrobial Resistance Benchmark launches on 21 January

10 January 2020

Fusion Genomics Receives $1 Million Award to Evaluate Novel Genomic Diagnostics Platform in Collaboration with Sunnybrook Research Institute

9 January 2020

The skyrocketting need for speed: partnering to develop rapid diagnostic tests that protect patients from antibiotic resistant infections during disasters and every day

9 January 2020

Phase Genomics Receives $1.5MM NIH Grant to Develop Fast and Affordable Commercial Antimicrobial Resistance Tracking Kit

9 January 2020

CARB-X funds TAXIS PHARMACEUTICALS to accelerate development of innovative efflux pump inhibitors (EPIS), a new drug class that would impair bacteria’s ability to fight antibiotics

8 January 2020

Phase Genomics Wins $1.5M for Proximity Ligation-Based AMR Tracking

8 January 2020

CARB-X backs Centauri to advance a new platform that combines antibiotic power with the ability to boost the immune system to fight infections caused by drug-resistant bacteria

8 January 2020

Antibiotics need a special place in the drug pricing debate

7 January 2020

GARDP developments

7 January 2020

Innovation Exchange to tackle NHS challenges around antimicrobial resistance

7 January 2020

Novo Holdings REPAIR Impact Fund invests USD12m in Mutabilis and IBT Vaccines

6 January 2020

The ‘broken’ antimicrobial market: A ‘looming cloud’ over medicine

6 January 2020

Antibiotics maker Melinta files for Chapter 11 bankruptcy

6 January 2020

Antibiotic Makers Struggle, Hurting War on Superbugs

4 January 2020

Why cloud-based data collaboration tech could defend against superbug outbreaks

4 January 2020

Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)

3 January 2020

Antabio Awarded $4.4 Million from CARB-X for the Further Development of its New Treatment for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients

2 January 2020

Winners of Hacking AMR 2019

2 January 2020

Antibiotic developer Melinta files for bankruptcy

2 January 2020

Africa: Innovate4AMR in Geneva

2 January 2020

Biotia leverages next-gen sequencing, AI in battle against HAIs

15 December 2019

Researchers design polymer that can kill drug-resistant bacteria

13 December 2019

Hackathon: New Digital Ideas to Counteract Antibiotic Resistance

13 December 2019

Phage therapy shown to kill drug-resistant superbug

10 December 2019

Mathematical modelling for antibiotic resistance control policy: do we know enough?

7 December 2019

A new phage consortium hosts its first public lecture

6 December 2019

CARB-X is awarding Vedanta Biosciences, of Cambridge, MA, USA, up to $5.8 million in non-dilutive funding

6 December 2019

FDA authorizes marketing of diagnostic test that uses novel technology to detect MRSA bacteria

4 December 2019

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

3 December 2019

New IMI project “COMBINE” launched to accelerate the fight against antimicrobial resistance

2 December 2019

Antibiotic development — economic, regulatory and societal challenges

28 November 2019

Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination

26 November 2019

CARB-X funds VenatoRx Pharmaceuticals to support the development of a new class of oral antibiotics to treat multi-drug-resistant gonorrhea

25 November 2019

The global preclinical antibacterial pipeline

25 November 2019

MEGARes 2.0: a database for classification of antimicrobial drug, biocide and metal resistance determinants in metagenomic sequence data

25 November 2019

InsightRX pens antibiotic deal for its precision dosing software

22 November 2019

Global Initiative on Education in AMR Diagnostics (JPIAMR VRI)

9 November 2019

Antimicrobial Resistance Germany 2019

9 November 2019

Engineering a superbug fightback

7 November 2019

AMR: ENABLE selects Mutabilis candidate

7 November 2019

Small Change – Big Consequences: Low Level Antibiotic Exposure Drives Rapid Evolution of Multidrug Resistance in Microbial Biofilms

6 November 2019

Ares Genetic Launches Early Access Program for its Antibiotic Susceptibility Test

5 November 2019

We Need More than New Antibiotics to Fight Resistance

4 November 2019

Total Synthesis and Antimicrobial Evaluation of 23-Demethyleushearilide and Extensive Antimicrobial Evaluation of All Synthetic Stereoisomers of (16Z,20E)-Eushearilide and (16E,20E)-Eushearilide

4 November 2019

As deadly ‘superbugs’ outsmart antibiotics, a Penn scientist uses artificial intelligence to design new ones



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed